Home/Filings/4/0000899243-21-049011
4//SEC Filing

Beardsley Robert A 4

Accession 0000899243-21-049011

CIK 0001563577other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 6:30 PM ET

Size

6.8 KB

Accession

0000899243-21-049011

Insider Transaction Report

Form 4
Period: 2021-12-17
Beardsley Robert A
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Stock Option

    2021-12-1720,00095,651 total
    Exercise: $1.07Exp: 2022-11-25Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2021-12-17$1.07/sh+20,000$21,40088,191 total
Footnotes (1)
  • [F1]The option has fully vested and is currently exercisable.

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

Entity typeother

Related Parties

1
  • filerCIK 0001310845

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 6:30 PM ET
Size
6.8 KB